Abstract:Objective To investigate the clinical effect of Amifostine combined with Gemcitabine and Cisplatin in the treatment of advanced breast cancer.Methods A total of 140 patients with advanced breast cancer treated in the First Affiliated Hospital,School of Medicine,Shihezi University from May 2014 to June 2016 were selected as the study subjects.They were divided into experimental group and reference group by random number table method,with 70 cases in each group.The control group was treated with Gemcitabine and Cisplatin,and the experimental group was treated with Amifostine.The total effective rate,the total incidence of adverse reactions,the survival time and the 1-year and 2-year expected survival rates of the two groups were compared,and the pain of the two groups before and after treatment was observed.Results The total effective rate of the experimental group (71.43%) was higher than that of the reference group (58.57%),and the difference was statistically significant (P<0.05).The total incidence of adverse reactions in the experimental group (14.29%) was lower than that in the reference group (25.71%),and the difference was statistically significant (P<0.05).The survival time of the experimental group was longer than that of the reference group,and the 1-year and 2-year expected overall survival rate was higher than that of the reference group,the differences were statistically significant (P<0.05).After treatment,the pain score of the experimental group was lower than that of the reference group,the difference was statistically significant (P<0.05).The pain scores of the two groups after treatment was lower than those before treatment,the differences were statistically significant (P<0.05).Conclusion For patients with advanced breast cancer,Amifostine combined with Gemcitabine and Cisplatin can improve the therapeutic effect and reduce the total incidence of adverse reactions,which is worthy of promotion and application.
穆亚男. 氨磷汀联合吉西他滨与顺铂方案治疗晚期乳腺癌的临床效果[J]. 中国当代医药, 2020, 27(2): 87-90.
MU Ya-nan. Clinical effect of Amifostine combined with Gemcitabine and Cisplatin in the treatment of advanced breast cancer. 中国当代医药, 2020, 27(2): 87-90.